Connecting the Dots The Relevance of Scar in Nonischemic Cardiomyopathy**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. by Kadish, Alan H. & Rubenstein, Jason C.
C
T
i
A
C
D
M
f
i
i
b
n
t
a
h
m
c
t
c
f
m
M
v
D
a
c
p
t
b
c
p
s
n
c
p
r
d
p
w
i
e
t
i
i
h
b
v
o
v
w
e
w
h
s
m
c
s
c
s
w
c
a
b
m
p
n
V
f
r
u
w
s
p
d
b
v
v
t
c
v
a
M
e
V
c
l
f
*
v
A
F
i
f
Journal of the American College of Cardiology Vol. 53, No. 13, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2008.12.027EDITORIAL COMMENT
onnecting the Dots
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lan H. Kadish, MD, Jason C. Rubenstein, MD
hicago, Illinois
elayed-enhancement magnetic resonance imaging (DE-
RI) has emerged as the gold standard imaging technique
or defining myocardial scar with high resolution. Gadolin-
um contrast washes out of the blood pool and accumulates
n the extracellular space. Tissues with weak intracellular
onds and high amounts of noncellular space, such as
ecrotic tissue or fibrous scar, will develop higher concen-
rations of this magnetic resonance imaging (MRI) contrast
gent than will healthy tissues. Scar detected by DE-MRI
as been shown to closely match histologically proven
yocardial infarction (MI) (1). After an MI, cardiac myo-
ytes become necrotic and cause an inflammatory response
hat initiates fibroblast replication, which replaces the ne-
rotic tissue with noncellular collagen. This myocardial scar
ormation leads to cardiac dysfunction and ischemic cardio-
yopathy. The DE-MRI has shown prognostic value after
I for viability (1,2), functional recovery after MI (2),
entricular arrhythmia (3), and long-term mortality (4).
elayed enhancement has been shown to correlate with
reas of low voltage on electroanatomic mapping (5), and
an define critical targets of VT circuits during ablation in
atients with prior myocardial infarction (6). Presumably
he presence of scar, and in particular the border zone
etween scar and normal myocardium, allows re-entrant
ircuits to form.
See page 1138
Myocardial scar has also been detected by DE-MRI in
atients with nonischemic cardiomyopathy. Themechanism of
car formation in patients with nonischemic cardiomyopathy is
ot clear because neither obstructive coronary disease nor
linical ischemia is typically seen. Yet over one-half of these
atients also show macroscopic evidence of cardiac tissue
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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n part by a grant from St. Jude’s Cardiac Rhythm Management Division and a grant
rom the National Heart, Lung, and Blood Institute (R01 HL091069).eplacement with fibrous tissue. The regions of scarring may be
ifferent in these 2 disease processes; ischemia leads to a
redominately endocardial scar that may be transmural,
hereas scar in nonischemic cardiomyopathies tends to be
solated to the midwall or epicardium. In contrast to the studies
stablishing the utility of DE-MRI in ischemic cardiomyopa-
hy, fewer data are available on the clinical utility of DE-MRI
n the nonischemic population. A DE-MRI can differentiate
schemic from nonischemic cardiomyopathies based on en-
ancement patterns (7). The presence of enhancement has
een shown to be predictive of higher mortality as well as
entricular arrhythmia, even in the absence of coronary disease
r infarction (8). In nonischemic patients with monomorphic
entricular tachycardia (VT), basal scar has been associated
ith arrhythmia (9). However, prior studies have not clearly
stablished that VTs are related to DE-MRI scar in patients
ithout coronary disease, as has been shown in patients with
ealed infarction.
One challenge in catheter ablation of VT, especially in the
etting of nonischemic cardiomyopathy, is that origin of VT is
ore often intramural or epicardial than it is in patients with
oronary artery disease. Prior studies have examined the use of
urface QRS configuration in an attempt to distinguish endo-
ardial, midmyocardial, and epicardial origins of VT. Despite
ome encouraging preliminary results, algorithms in patients
ith nonischemic cardiomyopathy that utilize surface electro-
ardiogram only have not proven to be highly accurate (10). An
dditional technique to direct the site of origin for VT ablation
efore performing catheter ablation would be useful. Also,
onomorphic VT is often not reproducibly inducible in
atients with nonischemic dilated cardiomyopathy, and thus a
onmapping technique that can distinguish the site of origin of
T remains attractive.
In this issue of the Journal, Bogun et al. (11) provide
urther compelling evidence showing that myocardial scar-
ing, as identified by DE-MRI, is associated with ventric-
lar arrhythmias and extends this observation to patients
ith nonischemic cardiomyopathy. They also suggest that
car location can be a helpful guide to ablation. The study
opulation consisted of 29 patients with nonischemic car-
iomyopathy who had been referred for catheter ablation
ecause of either VT (n  9) or symptomatic premature
entricular complexes (n  20). Little information is pro-
ided about other comorbid diseases, but the average ejec-
ion fraction was 39%. Scar was classified as either endo-
ardial, epicardial, intramural, or transmural, and scar
olumes were quantified. Bogun et al. (11) showed that
lthough 48% of the study population had scar by DE-
RI, all patients referred for sustained VT had some
vidence of scar. In those patients in whom a critical site of
T was identified, it occurred within areas of scar in all
ases (11). In patients with predominantly intramural de-
ayed enhancement, catheter ablation was uniformly inef-
ective. Two patients had DE-MRI scar limited to the
picardial surface; neither of these patients had VTs that
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atients who had predominantly endocardial enhancement,
1% underwent successful catheter ablation of all VTs via an
ndocardial approach; the remaining 29% had a majority of
Ts eliminated. In the entire cohort, there were 66 targeted
rrhythmias, of which 36 (55%) were successfully ablated.
The primary finding of this study is that DE-MRI
nhancement can be used as a guide for VT and premature
entricular complex ablation, even in patients considered to
ave nonischemic cardiomyopathies. There are 2 potentially
mportant implications. This finding could have important
ignificance for planning invasive electrophysiologic inter-
entions. In addition, the results of this study further
einforce the concept that scar burden by DE-MRI may be
orrelated with the incidence of ventricular tachyarrhyth-
ia. Further studies are needed to define the role that
E-MRI may have in noninvasive risk prediction of sudden
ardiac death, in both the ischemic and the nonischemic
ardiomyopathy populations.
Some limitations of the study should be noted. Only 29
atients were included in the study. Only 2 had scar
onfined to the epicardial surface. Thus, the observations
ade in this patient population are extremely preliminary.
he number of patients with intramural scar was also
imited. Given the inaccuracies of registering MRI images
o electroanatomic maps (almost 5 mm in this study) and
he resolution of DE-MRI images (1.4 mm in-plane, 8 mm
ut-of-plane), it seems unlikely that the current technolo-
ies can be used to guide specific lesion delivery or identify
he critical sites of ablation. Nonetheless, the results of the
tudy by Bogun et al. (11) suggest that DE-MRI may be a
seful technique in patients with VT and nonischemic
ardiomyopathy.
Although not completely conclusive because of small
atient number, the results of this study suggest that scar
ocation, identified by DE-MRI before a catheter ablation
rocedure, may help localize sites for effective ablation. An
ndocardial approach, epicardial approach, or continued
rials of medical therapy may be appropriate depending on
car location. The data in this article seem strongest for the
bility of DE-MRI to distinguish between endocardial and
onendocardial sites of VT origin. If these findings are
onfirmed in a larger patient population, scar localization
ould represent an important adjunct of catheter ablation in
K
vonischemic dilated cardiomyopathy. This study also gives
ope that in the near-future DE-MRI image integration in
he electrophysiology laboratory will be a major component
f VT ablation navigation.
eprint requests and correspondence: Dr. Alan H. Kadish, 251
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